BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27770792)

  • 1. More frequent, more costly? Health economic modelling aspects of monitoring glaucoma patients in England.
    Boodhna T; Crabb DP
    BMC Health Serv Res; 2016 Oct; 16(1):611. PubMed ID: 27770792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation.
    Burr JM; Mowatt G; Hernández R; Siddiqui MA; Cook J; Lourenco T; Ramsay C; Vale L; Fraser C; Azuara-Blanco A; Deeks J; Cairns J; Wormald R; McPherson S; Rabindranath K; Grant A
    Health Technol Assess; 2007 Oct; 11(41):iii-iv, ix-x, 1-190. PubMed ID: 17927922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for ocular hypertension: an evidence synthesis and economic evaluation.
    Burr JM; Botello-Pinzon P; Takwoingi Y; Hernández R; Vazquez-Montes M; Elders A; Asaoka R; Banister K; van der Schoot J; Fraser C; King A; Lemij H; Sanders R; Vernon S; Tuulonen A; Kotecha A; Glasziou P; Garway-Heath D; Crabb D; Vale L; Azuara-Blanco A; Perera R; Ryan M; Deeks J; Cook J
    Health Technol Assess; 2012 Jun; 16(29):1-271, iii-iv. PubMed ID: 22687263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment.
    Kaplan RI; De Moraes CG; Cioffi GA; Al-Aswad LA; Blumberg DM
    JAMA Ophthalmol; 2015 May; 133(5):560-7. PubMed ID: 25741886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of resource utilization in the treatment of open-angle glaucoma between two cities in Finland: is more better?
    Hagman J
    Acta Ophthalmol; 2013 May; 91 Thesis 3():1-47. PubMed ID: 23621767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are practical recommendations practiced? A national multi-centre cross-sectional study on frequency of visual field testing in glaucoma.
    Fung SS; Lemer C; Russell RA; Malik R; Crabb DP
    Br J Ophthalmol; 2013 Jul; 97(7):843-7. PubMed ID: 23613506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness and cost utility of an organized screening programme for glaucoma.
    Vaahtoranta-Lehtonen H; Tuulonen A; Aronen P; Sintonen H; Suoranta L; Kovanen N; Linna M; Läärä E; Malmivaara A
    Acta Ophthalmol Scand; 2007 Aug; 85(5):508-18. PubMed ID: 17655612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
    Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
    Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma.
    van Gestel A; Webers CA; Severens JL; Beckers HJ; Jansonius NM; Hendrikse F; Schouten JS
    Acta Ophthalmol; 2012 Feb; 90(1):20-31. PubMed ID: 22289192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Utility Analysis of Glaucoma Medication Adherence.
    Newman-Casey PA; Salman M; Lee PP; Gatwood JD
    Ophthalmology; 2020 May; 127(5):589-598. PubMed ID: 31767436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The increased cost of medical services for people diagnosed with primary open-angle glaucoma: a decision analytic approach.
    Kymes SM; Plotzke MR; Li JZ; Nichol MB; Wu J; Fain J
    Am J Ophthalmol; 2010 Jul; 150(1):74-81. PubMed ID: 20493465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea.
    Choi JA; Song LD; Choi S; Park SM; Kwon JW; Jee D
    Medicine (Baltimore); 2019 Jan; 98(2):e14026. PubMed ID: 30633194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated imaging technologies for the diagnosis of glaucoma: a comparative diagnostic study for the evaluation of the diagnostic accuracy, performance as triage tests and cost-effectiveness (GATE study).
    Azuara-Blanco A; Banister K; Boachie C; McMeekin P; Gray J; Burr J; Bourne R; Garway-Heath D; Batterbury M; Hernández R; McPherson G; Ramsay C; Cook J
    Health Technol Assess; 2016 Jan; 20(8):1-168. PubMed ID: 26822760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease severity in newly diagnosed glaucoma patients with visual field loss: trends from more than a decade of data.
    Boodhna T; Crabb DP
    Ophthalmic Physiol Opt; 2015 Mar; 35(2):225-30. PubMed ID: 25545852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice.
    Elliott RA; Tanajewski L; Gkountouras G; Avery AJ; Barber N; Mehta R; Boyd MJ; Latif A; Chuter A; Waring J
    Pharmacoeconomics; 2017 Dec; 35(12):1237-1255. PubMed ID: 28776320
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.